FINOTTI, Alessia
 Distribuzione geografica
Continente #
NA - Nord America 17.851
AS - Asia 11.087
EU - Europa 8.672
SA - Sud America 1.800
Continente sconosciuto - Info sul continente non disponibili 666
AF - Africa 248
OC - Oceania 51
AN - Antartide 1
Totale 40.376
Nazione #
US - Stati Uniti d'America 17.341
SG - Singapore 4.059
CN - Cina 3.008
FI - Finlandia 2.181
IT - Italia 1.915
BR - Brasile 1.439
VN - Vietnam 1.091
PL - Polonia 1.088
HK - Hong Kong 873
DE - Germania 854
UA - Ucraina 591
GB - Regno Unito 516
TR - Turchia 417
FR - Francia 403
SE - Svezia 350
JP - Giappone 309
BD - Bangladesh 302
CA - Canada 265
RU - Federazione Russa 257
IN - India 237
ID - Indonesia 227
MX - Messico 156
AR - Argentina 137
NL - Olanda 137
ZA - Sudafrica 90
IQ - Iraq 82
ES - Italia 69
PK - Pakistan 65
EC - Ecuador 52
IR - Iran 51
CO - Colombia 49
VE - Venezuela 44
BE - Belgio 43
UZ - Uzbekistan 43
PH - Filippine 39
AU - Australia 38
MA - Marocco 38
MY - Malesia 36
AT - Austria 34
SA - Arabia Saudita 34
CZ - Repubblica Ceca 33
LT - Lituania 32
GR - Grecia 31
CL - Cile 28
KR - Corea 26
AE - Emirati Arabi Uniti 25
JM - Giamaica 23
EG - Egitto 22
CH - Svizzera 21
KE - Kenya 20
RO - Romania 20
IE - Irlanda 18
PT - Portogallo 18
PY - Paraguay 18
TH - Thailandia 18
TN - Tunisia 17
AZ - Azerbaigian 15
DZ - Algeria 15
IL - Israele 15
JO - Giordania 14
NP - Nepal 13
UY - Uruguay 13
CR - Costa Rica 12
ET - Etiopia 12
PE - Perù 12
TW - Taiwan 12
KG - Kirghizistan 11
NZ - Nuova Zelanda 11
KZ - Kazakistan 9
LB - Libano 9
LV - Lettonia 9
PA - Panama 9
DO - Repubblica Dominicana 8
HN - Honduras 8
BO - Bolivia 7
RS - Serbia 7
LY - Libia 6
AO - Angola 5
BB - Barbados 5
BG - Bulgaria 5
BH - Bahrain 5
HR - Croazia 5
HU - Ungheria 5
NI - Nicaragua 5
OM - Oman 5
PS - Palestinian Territory 5
SI - Slovenia 5
TT - Trinidad e Tobago 5
AL - Albania 4
DK - Danimarca 4
GE - Georgia 4
KW - Kuwait 4
LK - Sri Lanka 4
NO - Norvegia 4
YE - Yemen 4
DM - Dominica 3
GT - Guatemala 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SV - El Salvador 3
Totale 39.655
Città #
Singapore 2.438
Ashburn 2.381
Helsinki 1.966
San Jose 1.359
Beijing 1.151
Woodbridge 1.129
Fairfield 1.123
Warsaw 1.075
Santa Clara 864
Hong Kong 850
Chandler 775
Ann Arbor 772
Houston 696
Jacksonville 656
Seattle 471
Wilmington 469
Ferrara 457
Council Bluffs 429
Los Angeles 342
New York 342
Cambridge 339
Ho Chi Minh City 339
Tokyo 290
Dallas 284
Hanoi 252
Nanjing 250
Munich 237
Izmir 228
Lauterbourg 205
Princeton 199
Jakarta 176
Milan 157
Shanghai 140
Addison 130
Boardman 130
Bologna 128
São Paulo 117
Bremen 111
Orem 98
Redwood City 93
San Diego 92
London 88
Mexico City 88
Shenyang 85
Verona 85
Turku 81
Rome 77
Chicago 74
Toronto 73
Brooklyn 69
Montreal 68
Hefei 67
Rio de Janeiro 63
Buffalo 61
Nanchang 61
Denver 58
Falls Church 58
Phoenix 55
The Dalles 55
Chennai 53
Da Nang 53
Frankfurt am Main 48
Hebei 48
Moscow 48
San Francisco 48
Dong Ket 47
Stockholm 46
Atlanta 45
Johannesburg 44
Dearborn 43
Hangzhou 43
Changsha 42
Guangzhou 40
Boston 38
Haiphong 38
Jiaxing 38
Manchester 38
Amsterdam 37
Tashkent 37
Brussels 35
Tianjin 35
Jinan 34
Mountain View 33
Curitiba 32
Poplar 32
Zhengzhou 32
Norwalk 31
Auburn Hills 30
Baghdad 30
Columbus 30
Dhaka 28
Brasília 27
Naples 27
Washington 27
Ankara 26
Des Moines 26
Nuremberg 26
Belo Horizonte 25
Biên Hòa 24
Falkenstein 23
Totale 26.493
Nome #
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 2.027
Transient Receptor Potential Ankyrin 1 Channels Modulate Inflammatory Response in Respiratory Cells from Patients with Cystic Fibrosis 435
A validated cellular biobank for β-thalassemia 419
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 418
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 381
Ground state naïve pluripotent stem cells and CRISPR/Cas9 gene correction for β-thalassemia 373
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 370
A validated THALAMOSS cellular biobank for β-thalassemia 342
Changes in hemoglobin profile reflect autologous blood transfusion misuse in sports 315
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 309
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 301
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 301
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 282
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 278
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 271
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 265
SPR-based non-invasive prenatal testing for fetal sex determination 263
Impiego di strategie di microRNA targeting combinate a trattamenti con composti di origine naturale ad attività antiproliferativa e pro-apoptotica: studio dell’effetto antitumorale in-vitro su modelli cellulari di carcinoma del colon-retto, di glioblastoma e di carcinoma mammario (NaturalMiR-Combo)” 262
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 251
A peptide nucleic acid against microrna miR-145-5p enhances the expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells 246
High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222 245
Possible detection of Autologous Blood Transfusion (ABT) based on circulating plasma microRNAs involved in erythroid differentiation and fetal hemoglobin induction 245
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 244
Altered erythroid-related miRNA levels as a possible novel biomarker for detection of autologous blood transfusion misuse in sport 242
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 238
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 237
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 235
Isothermal circular-strand-displacement polymerization of DNA and microRNA in digital microfluidic devices 234
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 230
A liquid biopsy model: Circulating miRNA levels in mice bearing colorectal carcinoma tumor xenografts 227
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 227
Induction of apoptosis of human glioma cell lines: Effects of combined treatment with corilagin and temozolomide 225
Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line 225
Epigenetic changes as a common trigger of muscle weakness in congenital myopathies 224
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 224
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 220
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 218
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 218
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 217
Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiae 215
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 215
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 212
AGENTI TRASFETTANTI PER ACIDI PEPTIDO-NUCLEICI 211
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity 211
Regulation of IL-8 gene expression in gliomas by microRNAs 206
Constitutive systemic inflammation in Shwachman-Diamond Syndrome 204
Antiproliferative and Erythroid Differentiation Activities of Cedrus libani Seed Extracts against K562 Human Chronic Myelogenus Leukemia Cells 203
Digital microfluidic devices for isothermal circular strand displacement polymerization of microRNAs 203
Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression 199
Regulation of IL-8 gene expression in gliomas by microRNA miR-93 195
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma 195
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 194
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 193
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 193
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs 192
Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review) 192
New insights into the Shwachman-Diamond Syndrome-related haematological disorder: Hyper-activation of mTOR and STAT3 in leukocytes 191
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 190
Cellular biosensors for the identification of fetal hemoglobin inducers 189
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 189
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 189
Development of microRNA based protocols for detection of autologous blood transfusion in sport 189
Demonstrating specificity of bioactive peptide nucleic acids (PNAs) targeting microRNAs for practical laboratory classes of applied biochemistry and pharmacology 189
Alteration of microRNA biological activity with peptide nucleic acid 188
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 188
A distinctive microrna (Mirna) signature in the blood of colorectal cancer (crc) patients at surgery 186
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 185
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 183
A PNA-based masking strategy for CFTR upregulation by targeting miR-145-5p binding sites of CFTR mRNA 183
Development and molecular characterization of transgenic mice for beta-thalassemia 180
Structural characterization of promoter sequences of the gene coding human PKI55 protein, a protein kinase C inhibitor 179
Efficient Delivery of MicroRNA and AntimiRNA Molecules Using an Argininocalix[4]arene Macrocycle 179
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 178
A peptide nucleic acid targeting the acpP gene of Pseudomonas aeruginosa inhibits bacterial induced biological alterations in cystic fibrosis cells 177
PCR detection of segmented filamentous bacteria in the terminal ileum of patients with ulcerative colitis 176
Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti-tubulin tetrahydrothieno[2,3-c]pyridine derivative and a peptide nucleic acid targeting miR-221-3p 176
A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1 176
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 176
A peptide nucleic acid (PNA) masking the miR-145-5p binding site of the 3’UTR of the cystic fibrosis transmembrane conductance regulator (CFTR) mRNA enhances CFTR expression in Calu-3 cells 175
miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs 174
Circulating microRNAs and liquid biopsy: murine xenograft models for technical validation of clinical protocols 174
Bovine serum amine oxidase and spermine cause apoptosis in cancer cells detected by flow cytometry, real time RT-PCR and proteomic analyses 169
Analysis of the miRNome as a possible tool for the detection of autologous blood transfusion misuse in sport 169
Modulation of the Biological Activity of microRNA-210 with Peptide Nucleic Acids (PNAs) 168
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 167
Pro‑apoptotic activity of novel synthetic isoxazole derivatives exhibiting inhibitory activity against tumor cell growth in vitro 166
Real-time multiplex analysis of four beta-thalassemia mutations employing surface plasmon resonance and biosensor technology 163
Involvement of miRNA in erythroid differentiation 161
Targeting microRNAs involved in human diseases: A novel approach for modification of gene expression and drug development 160
Antiproliferative and erythroid differentiation of piperazine and triphenyl derivatives against k-562 human chronic myelogenous leukemia. 159
Targeting the miR-221/miR-222 cluster in cancer therapy 158
Acidi peptido-nucleici (PNA) per il Genome Editing in β-talassemia: correzione sito-specifica della mutazione β°39 158
Synthesis and biological evaluation of new antitubulin agents containing 2-(30,40,50-trimethoxyanilino)-3,6-disubstituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine Scaffold 158
Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. 157
AGENTI TRASFETTANTI PER microRNA E antagomiRNA 157
A personalized medicine approach for beta-thalassemia patients: testing sirolimus in a first pilot clinical trial (sirthalaclin) 157
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients 156
INTRACELLULAR CALCIUM MOBILIZATION AND THE INFLAMMATORY RESPONSE IN CF BRONCHIAL EPITHELIAL CELLS 156
In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR 156
Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells 155
Totale 23.526
Categoria #
all - tutte 179.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.201
Totale 185.295


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.887 0 179 129 93 138 107 141 96 95 170 182 557
2022/20231.959 230 191 41 240 322 224 125 179 205 16 106 80
2023/20241.494 84 182 63 42 188 251 121 86 24 28 75 350
2024/20255.554 181 152 495 289 598 431 205 234 934 697 720 618
2025/202617.294 1.505 631 1.169 1.827 2.245 1.016 1.823 941 3.336 1.712 710 379
2026/20271.002 550 452 0 0 0 0 0 0 0 0 0 0
Totale 40.376